Electrochemotherapy of Primary Colon Rectum Cancer and Local Recurrence: Case Report and Prospective Analysis.
colorectal cancer
electrochemotherapy
endoscopic treatment
minimally invasive
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
12 May 2022
12 May 2022
Historique:
received:
14
04
2022
revised:
05
05
2022
accepted:
09
05
2022
entrez:
28
5
2022
pubmed:
29
5
2022
medline:
29
5
2022
Statut:
epublish
Résumé
Surgery, radiotherapy, and oncological treatment (chemotherapy and antineoplastic antibodies) are standard treatments of rectal cancer. ECT has shown its effectiveness and suitability in deep solid tumors conducted in both preclinical and clinical studies. We show here an update and preliminary results with locally advanced rectum cancer (LARC) treated with ECT. Two patients with major clinical response to restaging after neoadjuvant treatment for LARC were subjected to ECT 12 weeks after completing chemo-radiation therapy. One patient was subjected to ECT on a colorectal local recurrence formed after neoadjuvant treatment for LARC and surgery. Computed Tomography and Magnetic Resonance Imaging were used to assess ECT response. The results showed stable disease in two of the three patients treated, while one patient achieved a complete response. The local control of disease is maintained in the patient follow-up. For each patient, a reduction in pain was observed and for the patient with local recurrence, a reduction in bleeding present before ECT was also achieved. Preliminary results showed that ECT is a safe and effective treatment in patients with a major clinical response or local recurrence after neoadjuvant therapy for LARC and allows a reduction in pain and bleeding with a consequent improvement to quality of life.
Identifiants
pubmed: 35628872
pii: jcm11102745
doi: 10.3390/jcm11102745
pmc: PMC9143872
pii:
doi:
Types de publication
Case Reports
Langues
eng
Références
Radiol Med. 2021 Jul;126(7):998-1006
pubmed: 33861421
BMC Cancer. 2014 Nov 04;14:810
pubmed: 25369977
World J Gastroenterol. 2017 Jul 14;23(26):4767-4778
pubmed: 28765698
Updates Surg. 2016 Mar;68(1):93-7
pubmed: 27052544
Radiol Med. 2021 Mar;126(3):421-429
pubmed: 32833198
J Surg Oncol. 2014 Sep;110(3):320-7
pubmed: 24782355
Radiol Med. 2021 Nov;126(11):1434-1450
pubmed: 34338948
Eur J Cancer. 2016 Aug;63:41-52
pubmed: 27267144
Eur J Cancer. 2017 Dec;87:172-181
pubmed: 29156298
Radiol Med. 2021 Mar;126(3):437-444
pubmed: 33025303
Radiol Med. 2020 Aug;125(8):790-797
pubmed: 32206984
Biochem Pharmacol. 1988 Dec 15;37(24):4727-33
pubmed: 2462423
PLoS One. 2016 Aug 22;11(8):e0160732
pubmed: 27548058
CA Cancer J Clin. 2014 Mar-Apr;64(2):104-17
pubmed: 24639052
Eur J Surg Oncol. 2018 May;44(5):651-657
pubmed: 29402556
BMC Cancer. 2018 Jan 15;18(1):78
pubmed: 29334918
World J Gastroenterol. 2014 May 28;20(20):6113-22
pubmed: 24876733
Ann Surg. 2016 Mar;263(3):458-64
pubmed: 24263329
Radiol Med. 2021 Mar;126(3):494-497
pubmed: 33047296
Int J Mol Sci. 2022 Jan 17;23(2):
pubmed: 35055194
Acta Oncol. 2018 Jul;57(7):874-882
pubmed: 29577784
Endosc Int Open. 2018 Jun;6(6):E727-E734
pubmed: 29868638
Radiol Med. 2020 Dec;125(12):1288-1300
pubmed: 32415476
J Clin Oncol. 2015 Jun 1;33(16):1797-808
pubmed: 25918296
Technol Cancer Res Treat. 2016 Dec;15(6):737-748
pubmed: 26351303
Ann Surg Oncol. 2009 Jan;16(1):191-9
pubmed: 18987914
Eur J Surg Oncol. 2013 Jan;39(1):4-16
pubmed: 22980492
Cancer. 1993 Dec 15;72(12):3694-700
pubmed: 7504576
BMC Cancer. 2014 Nov 24;14:875
pubmed: 25421252
Radiol Med. 2021 Aug;126(8):1044-1054
pubmed: 34041663
Radiol Med. 2020 Dec;125(12):1216-1224
pubmed: 32410063
Radiol Med. 2021 Feb;126(2):323-333
pubmed: 32594427
Radiol Med. 2020 Jun;125(6):522-530
pubmed: 32020526
Br J Surg. 2012 Jun;99(6):821-30
pubmed: 22508342
Radiol Med. 2021 Jun;126(6):745-760
pubmed: 33523367
Diagn Interv Imaging. 2019 May;100(5):309-311
pubmed: 30691970
Radiol Oncol. 2015 Mar 25;49(2):147-54
pubmed: 26029026
Radiol Med. 2020 Jan;125(1):15-23
pubmed: 31587182
Int J Radiat Oncol Biol Phys. 2011 Mar 1;79(3):670-6
pubmed: 20472346
Radiol Med. 2020 Nov;125(11):1024-1039
pubmed: 32930945
Radiol Med. 2020 Sep;125(9):801-815
pubmed: 32249391
Radiol Med. 2020 Oct;125(10):990-998
pubmed: 32277332
Cancers (Basel). 2021 Jun 26;13(13):
pubmed: 34206858
Cancer Res. 1995 Aug 1;55(15):3450-5
pubmed: 7614485
Colorectal Dis. 2006 Nov;8(9):733-47
pubmed: 17032318
C R Acad Sci III. 1991;313(13):613-8
pubmed: 1723647
CA Cancer J Clin. 2015 Mar;65(2):87-108
pubmed: 25651787
Technol Cancer Res Treat. 2018 Jan 1;17:1533033818809994
pubmed: 30411673
Biomed Eng Online. 2015;14 Suppl 3:S5
pubmed: 26356120
Radiol Oncol. 2016 Feb 16;50(1):14-20
pubmed: 27069445
Radiol Med. 2020 Dec;125(12):1225-1232
pubmed: 32415477
Radiol Med. 2021 Oct;126(10):1296-1311
pubmed: 34213702
World J Gastroenterol. 2017 Feb 7;23(5):906-918
pubmed: 28223736
Eur J Surg Oncol. 2020 Sep;46(9):1628-1633
pubmed: 32387070
Int J Surg. 2017 Aug;44:26-32
pubmed: 28624558
BMC Cancer. 2010 Jun 21;10:309
pubmed: 20565923
Radiol Med. 2021 Dec;126(12):1561-1570
pubmed: 34415507
Br J Cancer. 2006 Jun 19;94(12):1809-15
pubmed: 16736001
Diagnostics (Basel). 2021 Aug 21;11(8):
pubmed: 34441441
Oncotarget. 2015 Oct 6;6(30):30394-407
pubmed: 26320185
Eur J Surg Oncol. 2018 Oct;44(10):1603-1609
pubmed: 30017329
Technol Cancer Res Treat. 2011 Oct;10(5):475-85
pubmed: 21895032